1-4 of 4
Steve E. Christmas
Close
Sort by
Journal Articles

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Kate L E Phillips, PhD, Joanne E Dean, BSc, Brian F Flanagan, PhD, Steve E Christmas, DPhil, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 2524.
https://doi.org/10.1182/blood.V128.22.2524.2524
Published: 2016
Journal Articles

Normal Lymphocytes at Diagnosis and during Induction Chemotherapy in Childhood Acute Lymphoblastic Leukaemia in Peripheral Blood and Bone Marrow Are Predominantly CD3+, CD4+ or CD8+, CCR7+, CD45RA+, HLA-DR-

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 4982.
https://doi.org/10.1182/blood.V126.23.4982.4982
Published: 2015
Journal Articles

Application of Human Immunophenotyping Consortium Panels to Early Childhood Leukaemia; From Diagnosis to End of Induction Chemotherapy

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 4995.
https://doi.org/10.1182/blood.V126.23.4995.4995
Published: 2015
Journal Articles

BCR-ABL–specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation

Nauman M. Butt, Lihui Wang, Hazem M. Abu-Eisha, Steve E. Christmas, Richard E. Clark
Journal: Blood
Blood (2004) 103 (8): 3245.
https://doi.org/10.1182/blood-2003-11-4086
Published: 2004